Alan B. Lancz & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Hold
5,537
1.22% 18
2026
Q1
$1.35M Sell
5,537
-770
-12% -$179K 1.31% 15
2025
Q4
$1.31M Hold
6,307
1.15% 18
2025
Q3
$1.17M Hold
6,307
1.06% 21
2025
Q2
$963K Sell
6,307
-50
-0.8% -$7.69K 0.96% 26
2025
Q1
$1.05M Hold
6,357
1.12% 21
2024
Q4
$919K Sell
6,357
-100
-2% -$15.5K 0.93% 24
2024
Q3
$1.05M Hold
6,457
0.96% 25
2024
Q2
$944K Buy
+6,457
New +$960K 0.93% 24
2023
Q4
$998K Hold
6,369
1.05% 19
2023
Q3
$992K Sell
6,369
-700
-10% -$116K 1.13% 19
2023
Q2
$1.17M Hold
7,069
1.25% 18
2023
Q1
$1.1M Sell
7,069
-50
-0.7% -$8.07K 1.14% 18
2022
Q4
$1.23M Hold
7,119
1.25% 17
2022
Q3
$1.16M Sell
7,119
-100
-1% -$16.9K 1.38% 15
2022
Q2
$1.26M Sell
7,219
-815
-10% -$145K 1.25% 17
2022
Q1
$1.42M Hold
8,034
1.26% 16
2021
Q4
$1.37M Buy
+8,034
New +$1.32M 1.2% 18

Other funds holding JNJ

Alan B. Lancz & Associates's JNJ Position: Q2 2026 in Review

Alan B. Lancz & Associates held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 5,537 shares worth $1.41M. The position accounts for 1.22% of the portfolio, ranked #18.

Alan B. Lancz & Associates first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.42M in Q1 2022. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Alan B. Lancz & Associates held 5,537 shares of Johnson & Johnson worth $1.41M as of Q2 2026.
  • Alan B. Lancz & Associates left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 1.22% of Alan B. Lancz & Associates's portfolio in Q2 2026, its #18 holding.
  • Alan B. Lancz & Associates first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • Alan B. Lancz & Associates's Johnson & Johnson position peaked at $1.42M in Q1 2022.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Alan B. Lancz & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.